The results showed that upregulating PLAGL2 could alleviate pulmonary damage, reduce apoptosis, and inhibit the development of BPD by reactivating the HIF-1α/VEGF signaling pathway that had been suppressed by hyperoxia. This evidence concerns the gene VEGFA and bronchopulmonary dysplasia.